ARTHUR TZIANABOS Insider Trading
Get free email notifications about insider trading for ARTHUR TZIANABOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARTHUR TZIANABOS. ARTHUR TZIANABOS is a Director in BIND Therapeutics, Inc ($BIND) and a Chief Scientific Officer in OvaScience, Inc. ($OVAS) and a President and CSO in OvaScience, Inc. ($OVAS) and a Director in Stoke Therapeutics, Inc. ($STOK) and a President & CEO in Homology Medicines, Inc. ($FIXX).
Address: C/O OVASCIENCE, INC., 215 FIRST STREET, SUITE 240 CAMBRIDGE 02142 MA
Companies in which ARTHUR TZIANABOS is an Insider
DNIB UNWIND, INC.
Trading Symbol: BINDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: Director
Holdings: 15,000 shares
Latest Transaction: Aug 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Homology Medicines, Inc.
Trading Symbol: FIXXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: President & CEO
Holdings: 77,505 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Millendo Therapeutics, Inc.
Trading Symbol: OVASIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: President and CSO, Chief Scientific Officer
Holdings: 25,400 shares
Current Value: $37,846
Latest Transaction: Dec 07 2015
$OVAS Market Capitalization: $55.19M
$OVAS Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Stoke Therapeutics, Inc.
Trading Symbol: STOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARTHUR TZIANABOS: Director
Holdings: 10,000 shares
Latest Transaction: Feb 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ARTHUR TZIANABOS
Sentiment: All, BIND, FIXX, OVAS, STOK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | M | 2.19 | 10,000 | 21,900 | 13,447 | |
Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Sell | S | 60.67 | 10,000 | 606,652 | 0 | 10 K to 0 (-100.00 %) |
Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Buy | M | 2.19 | 10,000 | 21,900 | 10,000 | 0 to 10 K |
Feb 09 2021 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
Feb 09 2021 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 13.78 | 254,000 | 3,500,120 | 254,000 | |
Jun 05 2020 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
Feb 05 2020 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.16 | 12,500 | 202,021 | 77,505 | 90 K to 77.5 K (-13.89 %) |